Cellular Biomedicine Group Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (22)

Latest Posts

About This Stock More About This Stock
U.S. Stock Market: AYX, BABA, BIDU, CAT, CBMG, CDNA, CDXS
Video By: Peter Mathers
Wednesday, September 30, 2020 3:46 AM EDT
A technical analysis covering Alteryx Inc, Alibaba Group, Baidu Inc, Caterpillar Inc, Cellular Biomedicine Group, CareDx Inc, and Codexis Inc.
In this video: CAT, BIDU, CDXS, BABA, CBMG, CDNA, AYX
Watch
Week In Review: Yantai's MabPlex Raises $59 Million To Expand CDMO Services
Article By: ChinaBio® Today
Sunday, January 20, 2019 10:38 AM EDT
MabPlex, a biologics CDMO, raised $59 million in a Series A round from SDIC Venture Fund and Shenzhen Venture Capital. MabPlex offers biologics development and manufacturing services, including mAbs, recombinant proteins, ADCs and bispecifics.
In this article: AZN, IRWD, CBMG, BGNE
Read
Week In Review: China Life Science Starts Off 2019 With $425 Million In Deals
Article By: ChinaBio® Today
Sunday, January 13, 2019 1:18 PM EDT
China's life science sector started off 2019 with $425 million from ten deals involving Apollomics, Schrödinger of New York City and BrightGene Bio-Medical of Suzhou, among others.
In this article: NVS, SPRO, CBMG, BHVN, ASLN
Read
Week In Review: Shanghai Henlius To File For Hong Kong IPO At Valuation Of Over $1 Billion
Article By: ChinaBio® Today
Saturday, October 6, 2018 5:57 PM EDT
Shanghai Fosun Pharma announced it will seek a Hong Kong IPO for Shanghai Henlius Biotech, its monoclonal antibody JV subsidiary The company was established to develop mAb biosimilar drugs, bio-betters and novel mAbs.
In this article: GILD, CBMG
Read
Week In Review: Agilent Pays $250 Million To Acquire ACEA And Its Cell Therapy Analyzer
Article By: ChinaBio® Today
Saturday, September 29, 2018 4:11 PM EDT
ACEA Biosciences, a San Diego company with R&D and manufacturing facilities in Hangzhzou, will be acquired by Agilent for $250 million in cash. ACEA developed the xCELLigence® cell therapy analysis device used by academic and biopharma researchers.
In this article: A, VSTM, NVS, CBMG, TTPH
Read

PARTNER HEADLINES

Latest Tweets for $CBMG

No tweets yet!